Stock GHDN BRAINSTORM CELL THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Brainstorm Cell Therapeutics Inc. Deutsche Boerse AG

Equities

GHDN

US10501E2019

Market Closed - Deutsche Boerse AG
Other stock markets
 07:12:54 27/06/2024 BST 		5-day change 1st Jan Change
0.355 EUR -0.28% Intraday chart for Brainstorm Cell Therapeutics Inc. -5.96% +54.35%
06-27 Brainstorm Cell Therapeutics Prices Registered Direct Offering, Concurrent Private Placement MT
06-26 Brainstorm Cell Therapeutics Inc. Reaches Alignment with Fda on Cmc Aspects of Phase 3B Nurown®? Clinical Trial CI

Chart calendar Brainstorm Cell Therapeutics Inc.

68a4680a613.KmoLYBxQ2OyOZBVjCAv82G-E1zjdXxZvWYZ8mUTmjbw.TixbP2gknJq6I0MOWFGJml7qjVqEC29fMMER2nWT0vZDBVJXVgCxu_QQfg~3d1b56e30c2245cbfbaccac7e5f2a9d4

Upcoming events on Brainstorm Cell Therapeutics Inc.

11/08/2024 Q2 2024 Earnings Release (Projected)
10/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)
18/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Brainstorm Cell Therapeutics Inc.

14/05/2024 21:30 Q1 2024 Earnings Release
09/04/2024 13:00 Business Update Call
01/04/2024 13:05 Q4 2023 Earnings Release
05/03/2024 European Life Sciences CEO Forum
04/03/2024 23:00 MDA Clinical and Scientific Conference
28/02/2024 16:20 European Life Sciences CEO Forum
28/02/2024 12:40 European Life Sciences CEO Forum
17/12/2023 Annual General Meeting
14/11/2023 13:30 Q3 2023 Earnings Call
14/11/2023 12:05 Q3 2023 Earnings Release
18/10/2023 13:30 Business Update Call
26/09/2023 ADCOM Conference
14/08/2023 13:00 Q2 2023 Earnings Call
14/08/2023 12:05 Q2 2023 Earnings Release
05/07/2023 17:00 Gordon Research Conference
21/06/2023 14:00 Maxim Group Virtual Healthcare Conference
15/05/2023 13:00 Q1 2023 Earnings Call
15/05/2023 12:05 Q1 2023 Earnings Release
30/03/2023 13:00 Q4 2022 Earnings Call
30/03/2023 12:05 Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
-14,0

EBIT
Million USD		Released
Forecast
Spread 		-23,0
-20,4
-13%		-31,7
-26,3
-20.41%		-24,5
-29,0
15.32%		-24,8
-25,9
4.18%		-21,4
-25,3
15.2%
-14,5

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-23,3
-20,5
-13.33%		-31,8
-26,1
-21.82%		-24,5
-28,7
14.93%		-24,3
-25,5
4.66%		-17,2
-25,2
31.71%
-21,9

Net income
Million USD		Released
Forecast
Spread 		-23,3
-20,2
-15.39%		-31,8
-26,1
-21.82%		-24,5
-28,7
14.93%		-24,3
-25,5
4.66%		-17,2
-23,0
25.37%
-21,9

EPS
USD		Released
Forecast
Spread 		-1,06
-0,91
-17.13%		-1,07
-0,89
-20.22%		-0,68
-0,79
13.92%		-0,66
-0,68
2.22%		-0,40
-0,56
28.57%
-0,28

Announcement Date18/02/2004/02/2128/03/2230/03/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-5,48
-4,70
-16.49%		-7,59
-5,46
-39.14%		-6,84
-6,75
-1.39%		-4,92
-6,00
18.08%		-5,15
-6,01
14.24%		-5,45
-5,70
4.43%		-6,04
-6,00
-0.56%		-4,80
-6,33
24.1%		-2,47
-4,50
45.02%
-5,20


-5,80


-6,40

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-5,36
-4,70
-14.04%		-7,04
-5,46
-29.06%		-6,86
-6,75
-1.65%		-5,02
-6,00
16.37%		-5,06
-5,96
15.06%		-5,33
-5,65
5.71%		-1,23
-6,00
79.57%		-5,58
-6,33
11.87%		-3,40
-4,50
24.42%
-5,20


-5,80


-6,40

Net income
Million USD		Released
Forecast
Spread 		-5,36
-4,70
-14.04%		-7,04
-5,46
-29.06%		-6,86
-6,75
-1.65%		-5,02
-6,00
16.37%		-5,06
-5,96
15.06%		-5,33
-5,65
5.71%		-1,23
-6,00
79.57%		-5,58
-6,33
11.87%		-3,40
-4,50
24.42%
-5,20


-5,80


-6,40

EPS
USD		Released
Forecast
Spread 		-0,15
-0,13
-15.38%		-0,19
-0,15
-31.03%		-0,19
-0,18
-5.56%		-0,13
-0,15
10.34%		-0,14
-0,17
15.15%		-0,13
-0,15
10.34%		-0,03
-0,15
79.31%		-0,11
-0,13
15.38%		-0,05
-0,07
28.57%
-0,07


-0,06


-0,07

Announcement Date16/05/2215/08/2214/11/2230/03/2315/05/2314/08/2314/11/2301/04/2414/05/24---

Upcoming sector events for Brainstorm Cell Therapeutics Inc.

15/07/2024 06:45 ADDLIFE AB: Q2 2024 Earnings Release
21/07/2024 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
23/07/2024 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
23/07/2024 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
24/07/2024 LONZA GROUP AG: Q2 2024 Earnings Release
25/07/2024 06:00 BACHEM HOLDING AG: Q2 2024 Earnings Release
25/07/2024 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
26/07/2024 06:00 BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for Brainstorm Cell Therapeutics Inc.

07/06/2024 07:57 POLARIS GROUP: May 2024 Sales and Revenue Release
29/05/2024 21:01 IMMUNOVANT, INC.: Q4 2024 Earnings Release
23/05/2024 12:00 CUREVAC N.V.: Q1 2024 Earnings Release
22/05/2024 06:00 EVOTEC SE: Q1 2024 Earnings Release
21/05/2024 22:14 ALVOTECH: Q1 2024 Earnings Release
21/05/2024 12:00 EXSCIENTIA PLC: Q1 2024 Earnings Release
17/05/2024 07:00 BIOARCTIC AB: Q1 2024 Earnings Release
15/05/2024 21:05 CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BCLI Stock
  4. GHDN Stock
  5. Calendar Brainstorm Cell Therapeutics Inc.